Business
Helix Acquisition Corp. III Announces Closing of $172.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares
January 27, 2026 BOSTON, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Helix Acquisition Corp. III (Nasdaq: HLXC) (the “Company”) announced today that on January 26,
About this update from Helix Acquisition Corp. Iii
[{"type":"text","content":"January 27, 2026 BOSTON, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Helix Acquisition Corp. III (Nasdaq: HLXC) (the “Company”) announced today that on January 26, 2026, it closed the initial public offering of 17,250,000 Class A ordinary shares, which includes 2,250,000 shares issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per share resulting in gross proceeds of $172,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by the Company. The Company is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on opportunities in healthcare or healthcare-related industries. The Company, sponsored by Helix Holdings III LLC, an affiliate of Cormorant Asset Management, is led by Bihua Chen as Chief Executive Officer and Chairperson, and Caleb Tripp as Chief Financial Officer and Chief Operating Officer. Concurrently with the closing of the initial public offering, the Company completed a private placement of 497,500 Class A ordinary shares at a price of $10.00 per share, to Helix Holdings III LLC, generating gross proceeds to the Company of $4,975,000. The Company’s Class A ordinary shares began trading on The Nasdaq Global Market under the ticker symbol “HLXC” on January 23, 2026. Leerink Partners and Oppenheimer & Co. are serving as the joint bookrunning managers for the offering. The offering was made only by means of a prospectus. Copies of the prospectus may be obtained from: Leerink Partners LLC, Attn: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, or by telephone at (800) 808-7525 ext. 6105, or by email at [email protected]; and Oppenheimer & Co. Inc. Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, or by telephone at (212) 667-8055, or by email at [email protected]. A total of $172,500,000 comprised of the net proceeds from the IPO and simultaneous private placement were placed in trust. An audited balance sheet of the Company as of January 26, 2026 reflecting receipt of t...